NeuroStar® Advanced Therapy's Depression Outcomes Registry Hits 10000 Patient Milestone StreetInsider.com
PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders GlobeNewswire
According to Latest Report on Insomnia Medication Market to Grow with an Impressive CAGR : Top Key Players Eisai, Dainippon Sumitomo, Sanofi, Merck, Astellas KSU | The Sentinel Newspaper
Some supplements might be able to help prevent illness, but doctors say patients should do research Oklahoman.com
New research on ketamine may lead to novel treatments for depression McGill Tribune
New patients lead rise in claims for antidepressants CBC.ca
What you need to know about COVID-19 in Ottawa on Tuesday, Jan. 19 CBC.ca
Scientists develop world's first test to accurately predict mood disorders News-Medical.Net
